Small cell type malignant melanoma which developed in a 16-year-old female with a congenital dermal nevus and metastasized 12 years after excision

Pathology International

Volumn 49, Issue 3, 1999, Pages 247-252

  Miura, Katsutoshi ^a   Harada, Hidekazu ^a   Tsutsui, Yoshihiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HMB 45; Ki 67; Lymphoblast; Malignant melanoma; p53

Indexed keywords

COLLAGEN FIBER; KI 67 ANTIGEN; MONOCLONAL ANTIBODY HMB 45; PROTEIN P53;

ADOLESCENT; ARTICLE; CANCER INVASION; CASE REPORT; CONGENITAL NEVUS; DERMIS; EXCISION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; LUNG METASTASIS; MEDIASTINUM METASTASIS; MELANOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032901393     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00855.x     Document Type: Article

References (14)

1. Slingluff Jr CL, Dodge RK, Stanley WE, Seigler HF. The annual risk of melanoma progression: Implications for the concept of cure. Cancer 1992; 70: 1917-1927.
2. Crowley NJ, Seigler HF. Late recurrence of malignant melanoma: Analysis of 168 patients. Ann. Surg. 1990; 212: 173-177.
3. Hendrickson M, Ross J. Neoplasms arising in congenital giant nevi. Am. J. Surg. Pathol. 1981; 5: 109-135.
4. Colombari R, Bonetti F, Zamboni G et al. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumors: An immunohistochemical study on paraffin sections. Virchows Arch. A Pathol. Anat. Histopathol. 1988; 413: 17-24.
5. Pratt CB, Palmer MK, Thatcher N, Crowther D. Malignant melanoma in children and adolescents. Cancer 1981; 47: 392-397.
6. Myhre E. Malignant melanoma in children. Acta Pathol. Microbiol. Scand. 1963; 59: 184-188.
7. Alien A, Spitz S. Malignant melanoma: A clinicopathologic analysis of the criteria for diagnosis and prognosis. Cancer 1953; 6: 1-45.
8. Walton R. Pigmented nevi. Pediatr. Clin. North Am. 1971; 18: 897-923.
9. Trozak D, Rowland W, Hu F. Metastatic malignant melanoma in prepubertal children. Pediatrics 1975; 55: 191-204.
10. Lorentzen M, Pers M, Bretteville-Jensen G. The incidence of malignant transformation in giant pigmented nevi. Scand. J. Plast. Reconstr. Surg. Hand Surg. 1977; 11: 163-167.
11. Rhodes AR, Sober AJ, Day CL et al. The malignant potential of small congenital nevocellular nevi: An estimate of association based on a histologic study of 234 primary cutaneous melanomas. J. Am. Acad. Dermatol. 1982; 6: 230-241.
12. Heenan P, Elder D, Sobin L. World Health Organization International Histological Classification of Tumors. Histological Typing of Skin Tumors, 2nd edn. Springer-Verlag, Berlin, 1996.
13. Reed W, Becker S, Becker SJ, Nickel W. Giant pigmented nevi, melanoma, and leptomeningeal melanosis. Arch. Dermatol. 1965; 91: 100-119.
14. Albino AP, Reed JA, McNutt NS. Molecular biology of cutaneous melanoma. In: DeVita Jr VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. Lippincott-Raven, Philadelphia, 1997; 1935-1946.